Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: A cohort study. (2023)

First Author: Zaccardi F
Attributed to:  Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dom.14872

PubMed Identifier: 36099041

Publication URI: http://europepmc.org/abstract/MED/36099041

Type: Journal Article/Review

Volume: 25

Parent Publication: Diabetes, obesity & metabolism

Issue: 2

ISSN: 1462-8902